Bilberry Extract

by Flora · capsule · 30 capsules

  • On the market (NIH)
  • UPC 0 61998 61346 7
  • DSLD label 73118
  • Serving 1 capsule

Bilberry Extract by Flora lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 220 mg of bilberry fruit extract and 100 mg of blueberry powder. Its current label entered the NIH Dietary Supplement Label Database on April 25, 2017.

What is in Bilberry Extract?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Bilberry Extract: Supplement Facts rows against the market (DSLD label 73118, January 2026 release)
IngredientAmount% DVAmong products listing it
Bilberry fruit extractas AnthocyaninsBilberry fruit extract (Form: 25% standardized Anthocyanins) PlantPart: fruit220 mgBilberry in Bilberry Extract against 896 products220 mg per serving; the middle half of products list 20 mg to 100 mg, the median 50 mg.220 mg

Higher than 86% of 896 products listing bilberry (median 50 mg). Per day at the most servings: 440 mg.

Blueberry powder100 mgBlueberry in Bilberry Extract against 378 products100 mg per serving; the middle half of products list 50 mg to 300 mg, the median 100 mg.100 mg

47% of 378 products listing blueberry give more (median 100 mg). Per day at the most servings: 200 mg.

Source: NIH ODS Dietary Supplement Label Database, label 73118 (entered April 25, 2017), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 1 to 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

3 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: Take 1 capsule in the morning and 1 capsule in the evening with meals.
Warnings
Security sealed for your protection. Do not use if seal is missing or damaged.
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 73118.

What else is on the label?

Other ingredients: Microcrystalline Cellulose, Magnesium Stearate, Vegetarian Capsule.

How many labels does Bilberry Extract have?

2 labels are on file under this name since May 23, 2014: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 73118 (current) Entered April 25, 2017 · on the market · 30 capsules · UPC 0 61998 61346 7
  2. Label 33713 Entered May 23, 2014 · off the market April 6, 2017 · 30 capsules · UPC 0 61998 61346 7

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Flora, Inc. (distributor), Lynden, WA. All Flora products.

Where next?